Medable has set up a subsidiary in Pfäffikon SZ. The U.S. company offers software that makes it easier to conduct clinical trials.
Medable has established a subsidiary in Pfäffikon, as was reported in a newsletter from the Office for Economy of the canton of Schwyz. The U.S. company has developed software for clinical trials. This makes it easier to recruit patients and helps in the collection and storage of data. The overall aim is to accelerate drug development through decentralized clinical trials.
With this expansion into the Greater Zurich Area, Medable wants to enable greater engagement with European pharma companies. In a press release, the importance of the cooperation with Swiss pharma groups was also highlighted.
Related documents
The PDF outlines why Greater Zurich is a top location for European expansion.
Learn more about the benefits of doing business in the Greater Zurich Area.
This fact sheet gives the hard data on why Switzerland is a medical technology hub.
Insights from biotech leaders regarding timing, regulations, and choice of location.
Related Success Stories
News
Contact us
Can we put you in touch with a peer company or research institute? Do you need any information regarding your strategic expansion to Switzerland's technology and business center?
info@greaterzuricharea.com